Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1995-6-23
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0903-1936
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
338
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7758574-Dyspnea,
pubmed-meshheading:7758574-Exercise Tolerance,
pubmed-meshheading:7758574-Humans,
pubmed-meshheading:7758574-Lung Diseases, Obstructive,
pubmed-meshheading:7758574-Parasympatholytics,
pubmed-meshheading:7758574-Perception,
pubmed-meshheading:7758574-Scopolamine Derivatives
|
pubmed:year |
1995
|
pubmed:articleTitle |
Chronic lung disease and the perception of breathlessness: clinical perspective.
|
pubmed:publicationType |
Letter,
Comment
|